Clinical benefit of treatment with eribulin mesylate for metastatic triple‐negative breast cancer: Long‐term outcomes of patients treated in the US community oncology setting von Mougalian, Sarah S., Copher, Ronda, Kish, Jonathan K., McAllister, Lindsay, Wang, Zhixiao, Broscious, Mary, Garofalo, David, Radtchenko, Janna, Feinberg, Bruce A.

Volltext